Projekt

MK-7902-005 A Multicenter, Open-label Phase 2 Study of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) in Previously Treated Subjects with Selected Solid Tumors (LEAP-005)

Laufend - Rekrutierung – beendet · 2021 bis 2030

Fischer Stefanie, Donno Monica, Quinter Janine